Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763457
Japanese Strabismus Outcomes Assessment and Research Group StudyKyoto University, Graduate School of MedicineNot Yet Recruiting
NCT07763457Not Yet Recruiting
—
Japanese Strabismus Outcomes Assessment and Research Group StudyKyoto University, Graduat...
NCT07763587
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Benefit Evaluation of Acupuncture Collaborative Management RegimenFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineNot Yet RecruitingNot Applicable
NCT07763587Not Yet Recruiting
Not Applicable
Analysis of Multimodal Psychosomatic Comorbidity Burden in Breast Cancer and Ben...First Teaching Hospital o...
NCT07762248
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular Permanent Molars With Necrotic Pulp and Apical PeriodontitisMohamed Ashraf AbdeenNot Yet RecruitingPhase 2
NCT07762248Not Yet Recruiting
Phase 2
Impact of Minimally Invasive Endodontic Treatment on the Prognosis of Mandibular...Mohamed Ashraf Abdeen
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763028
Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children With Cerebral PalsyGadjah Mada UniversityActive Not RecruitingPhase 1
NCT07763028Active Not Recruiting
Phase 1
Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children...Gadjah Mada University
NCT07764302
Enhancing Amoxicillin Pharmacokinetics and Pharmacodynamics Parameters With Probenecid in Bone and Joint InfectionsAssistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07764302Not Yet Recruiting
Phase 3
Enhancing Amoxicillin Pharmacokinetics and Pharmacodynamics Parameters With Prob...Assistance Publique - Hôp...
NCT07763899
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763899Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07764146
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's DiseaseVoyager TherapeuticsNot Yet RecruitingPhase 1
NCT07764146Not Yet Recruiting
Phase 1
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheim...Voyager Therapeutics
NCT07762235
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive ImpairmentIstinye UniversityNot Yet RecruitingNot Applicable
NCT07762235Not Yet Recruiting
Not Applicable
High-Amplitude Functional Exercises in Older Adults With Mild Cognitive Impairme...Istinye University
NCT07763990
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLERHallura Ltd.RecruitingNot Applicable
NCT07763990Recruiting
Not Applicable
THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FI...Hallura Ltd.
NCT07762040
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting Multiple SclerosisAssiut UniversityNot Yet Recruiting
NCT07762040Not Yet Recruiting
—
Predictors of Progression Independent of Relapse Activity in Relapsing Remitting...Assiut University
NCT07763015
Study of Resmetirom in Children and Adolescents With MASHMadrigal Pharmaceuticals, Inc.Not Yet RecruitingPhase 2
NCT07763015Not Yet Recruiting
Phase 2
Study of Resmetirom in Children and Adolescents With MASHMadrigal Pharmaceuticals,...
NCT07762768
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Response in Individuals With PrediabetesCSIR National Institute for Interdisciplinary Science and Technology (NIIST), ThiruvananthapuramNot Yet RecruitingNot Applicable
NCT07762768Not Yet Recruiting
Not Applicable
Effect of CSIR-Developed High-Protein, Low-Glycaemic Index Rice on Glycaemic Res...CSIR National Institute f...
NCT07762586
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)Rutgers, The State University of New JerseyRecruitingPhase 2
NCT07762586Recruiting
Phase 2
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NA...Rutgers, The State Univer...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07763119
Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration SyndromeKhyber Teaching HospitalCompletedPhase 3
NCT07763119Completed
Phase 3
Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration...Khyber Teaching Hospital
NCT07762339
Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Analgesia in Pediatric Patients Undergoing Orchiopexy: A Prospective Observational StudyProf. Dr. Cemil Tascıoglu Education and Research Hospital OrganizationRecruiting
NCT07762339Recruiting
—
Comparison of Erector Spinae Plane Block and Caudal Block for Postoperative Anal...Prof. Dr. Cemil Tascıoglu...
NCT07764133
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian CancerUniversity of Tennessee Graduate School of MedicineRecruiting
NCT07764133Recruiting
—
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation a...University of Tennessee G...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Completed4 (20%)
Active, not recruiting1 (5%)
not_applicable7 (35%)
Not Specified5 (25%)
Phase 24 (20%)
Phase 12 (10%)
Phase 32 (10%)